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Abstract
Background: The ST313 sequence type of Salmonella Typhimurium causes invasive non-typhoidal salmonellosis and was
thought to be confined to sub-Saharan Africa. Two distinct phylogenetic lineages of African ST313 have been identified.
Methods:We analysed the whole genome sequences of S. Typhimurium isolates from UK patients that were
generated following the introduction of routine whole-genome sequencing (WGS) of Salmonella enterica by
Public Health England in 2014.
Results: We found that 2.7% (84/3147) of S. Typhimurium from patients in England and Wales were ST313 and were
associated with gastrointestinal infection. Phylogenetic analysis revealed novel diversity of ST313 that distinguished
UK-linked gastrointestinal isolates from African-associated extra-intestinal isolates. The majority of genome degradation
of African ST313 lineage 2 was conserved in the UK-ST313, but the African lineages carried a characteristic prophage
and antibiotic resistance gene repertoire. These findings suggest that a strong selection pressure exists for certain
horizontally acquired genetic elements in the African setting. One UK-isolated lineage 2 strain that probably originated
in Kenya carried a chromosomally located blaCTX-M-15, demonstrating the continual evolution of this sequence type in
Africa in response to widespread antibiotic usage.
Conclusions: The discovery of ST313 isolates responsible for gastroenteritis in the UK reveals new diversity in this
important sequence type. This study highlights the power of routine WGS by public health agencies to make
epidemiologically significant deductions that would be missed by conventional microbiological methods. We
speculate that the niche specialisation of sub-Saharan African ST313 lineages is driven in part by the acquisition
of accessory genome elements.
Background
Serovars of Salmonella enterica cause infections in a diverse
range of hosts. In humans, Salmonella are responsible for a
broad range of clinical presentations, from gastroenteritis to
invasion of normally sterile compartments such as the
bloodstream or brain. Two serovars, Salmonella Typhi and
Salmonella Paratyphi A, are particularly associated with
both human-restricted and invasive disease. The
clinical syndrome caused by these serovars is known
as typhoid or enteric fever and this has led to the
remaining 2600 serovars being loosely described as
non-typhoidal. By inference, ‘non-typhoidal’ serovars
have been considered to be non-invasive in immuno-
competent individuals; this crude clinical distinction is
misleading [1].
These ‘non-typhoidal’ Salmonella (NTS) serovars typically
have a broad host-range and the majority of human cases
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are foodborne, often originating from zoonotic reservoirs
[2]. While most infections are typically associated with self-
limiting gastroenteritis, in a minority of cases (~5%) invasive
disease occurs, frequently due to human host immuno-
suppression, for example advanced HIV infection [3].
NTS are a significant public health burden worldwide
and S. Typhimurium and S. Enteritidis are the predominant
serotypes observed in clinical cases in most countries. In
England and Wales, 48.7% of the isolates referred to the
Salmonella Reference Service were S. Typhimurium or S.
Enteritidis in 2012 (Public Health England [PHE] data:
https://www.gov.uk/government/publications/salmonella-by-
serotype/salmonella-by-serotype-2000-to-2010).
The clinical distinction between typhoidal and non-
typhoidal disease is particularly unhelpful in sub-Saharan
Africa (sSA), where non-typhoidal serovars are among the
most common cause of bloodstream infection, a clinical
condition known as invasive non-typhoidal Salmonella
(iNTS) disease [1]. While the high prevalence of immuno-
suppressive illness such as HIV and malaria in sSA are
clear predisposing factors for the emergence of iNTS
disease as a major public health problem, the huge burden
of disease has led to further investigation into the serovars
responsible for iNTS disease. S. Typhimurium is the sero-
var most commonly associated with this condition [4].
Multi-locus sequence typing (MLST) is a molecular
approach for typing microorganisms and uses the allelic
variation of seven highly conserved Salmonella house-
keeping genes to infer bacterial phylogeny [5]. Whole-
genome sequencing (WGS) studies of isolates collected
from patients with iNTS disease in sSA initially identified
a novel sequence type (ST), ST313, of S. Typhimurium in
2009 [6]. Subsequent genome-based studies confirmed
two distinct phylogenetic lineages of ST313 associated
with iNTS and spatio-temporal phylogenetic reconstruction
suggested that lineage 1 emerged around 1960 in southwest
Africa, whereas lineage 2 emerged around 1977 in Malawi
[7]. Both lineages are associated with antimicrobial resist-
ance (AMR) mediated by differing Tn21-like integrons on
the virulence plasmid pSLT [6] and it was proposed that
clonal replacement of lineage 1 by lineage 2 had occurred,
driven by the acquisition of chloramphenicol resistance in
lineage 2 [7]. S. Typhimurium ST313 has recently been
detected in Brazil [8]. Unlike African ST313, the nine
Brazilian ST313 isolates were predominantly associated with
gastro-intestinal infection and were antibiotic-susceptible.
It has been suggested that the link between S. Typhimur-
ium ST313 and iNTS disease in sSA is that, compared
with the generalist S. Typhimurium ST19, ST313 has
adapted to an extra-intestinal/invasive lifestyle via genome
degradation [6, 9]. This would be consistent with the
finding of an accumulation of pseudogenes in pathways
associated with gastrointestinal colonisation, as observed
in host-restricted Salmonella serovars such as S. Typhi
and in Yersinia pestis, Shigella spp, Mycobacterium leprae
and Bordetella pertussis [10–16]. Another observation
from comparative genomic studies, which supports the
hypothesised enhanced virulence of ST313 includes the
detection of novel prophages BTP1 and BTP5 [17] includ-
ing the reported BTP1 phage-encoded putative virulence
gene, st313-td [18]. A number of phenotypic characteristics
which distinguish ST313 from gastroenteritis-associated
ST19 strains have been described, including a reduction in
motility, flagellin expression, stationary-phase catalase
activity and biofilm formation [19–21]. Despite these
phenotypes, it remains to be proven whether ST313 are
intrinsically capable of causing a higher level of systemic
disease than ST19.
Since 1st April 2014, every presumptive Salmonella
isolate received by the Salmonella Reference Service (SRS)
of PHE has had WGS to allow identification, characterisa-
tion and typing in one laboratory process [22].
In this study, we investigated the prevalence of ST313
in cases of laboratory-confirmed S. Typhimurium infec-
tions reported in England and Wales, obtained clinical data
regarding the origin of isolates (faeces or blood) and
contacted patients to determine whether infection was
associated with travel to high-incidence areas such as
sSA. We used a phylogenetic approach to place the
UK-isolated ST313 into the evolutionary context of ST313
lineages isolated in Africa (hereafter referred to as African
ST313). We then investigated the accessory genome,
multi-drug resistance (MDR) determinants and the pres-
ence of pseudogenes in the UK isolates to shed light
on the population structure and evolution of ST313
S. Typhimurium. We also compared key phenotypes of
the UK-isolated ST313 with the African ST313 lineage 2.
Methods
Strains and metadata
Genome sequences from a total of 333 S. Typhimurium
isolates dating from 2012 (of which 314 were from
human patients), and 3018 S. Typhimurium from 1st
January 2014 to 31st May 2016 (of which 2833 were from
human patients) were analysed for this study. Non-human
isolates originated from animal, food or environmental
sources. All Salmonella isolates sequenced by PHE are
available from the NCBI SRA BioProject PRJNA248064;
the accession numbers, along with isolation source,
for all 3351 S. Typhimurium genomes sequenced by
PHE within the timeframes stated above are listed in
Additional file 1: Table S1.
Of the total S. Typhimurium genomes sequenced in
2012 and 2014–2016, 7/333 (2.1%) and 79/3018 (2.6%)
were S. Typhimurium ST313, respectively. If only isolates
from human patients are included, 7/314 (2.2%) and 77/
2833 (2.7%) were S. Typhimurium ST313, respectively.
Full strain metadata and genome accession numbers can
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be found in Additional file 2: Table S2. Sequence data
(FASTQs) from 23 representative African ST313 isolates se-
quenced by Okoro et al. [7] were downloaded from
the European Nucleotide Archive (accession numbers
available in Additional file 2: Table S2) and analysed
in the same way as sequence data generated from
UK-isolated ST313 isolates.
Sequencing
DNA extraction for Illumina sequencing of Salmonella
isolates was carried out using a modified protocol of the
Qiasymphony DSP DNA midi kit (Qiagen). In brief,
0.7 mL of an overnight Salmonella culture in a 96-well
plate was harvested. Bacterial cells were pre-lysed in
220 μL of ATL buffer (Qiagen) and 20 μL Proteinase K
(Qiagen) and incubated with shaking for 30 min at 56 °C.
A total of 4 μL of RNase (100 mg/mL; Qiagen) was added
to the lysed cells and re-incubated for a further 15 min at
37 °C. This step increased the purity of the DNA for
downstream sequencing. DNA from the treated cells was
then extracted on the Qiasymphony SP platform (Qiagen)
and eluted in 100 μL of sterile water. DNA concentration
was derived using the GloMax system (Promega) and
quality (optimal OD260/230 = 1.8–2.0) was determined
using the LabChip DX system (Perkin Elmer). Extracted
DNA was prepared using the NexteraXT sample prepar-
ation method and sequenced with a standard 2 × 100 bp
protocol on a HiSeq 2500 instrument (Illumina, San
Diego, CA, USA). Raw FASTQs were processed with
Trimmomatic [23] and bases with a PHRED score < 30
removed from the trailing end.
Single molecule sequencing was performed on the PacBio
RS II instrument at the Centre for Genomic Research,
University of Liverpool. DNA was extracted from strain U2
using the Zymo Research Quick-DNA™ Universal Kit (cat.
no. D4069) as per the Biological Fluids & Cells proto-
col. Extracted DNA was purified with Ampure beads
(Agencourt) and the quantity and quality was assessed
by Nanodrop and Qubit assays. In addition, the Fragment
Analyser (VH Bio), was used to determine the average size
of the DNA, using a high sensitivity genomic kit. DNA was
sheared to approximately 10 kb using a Covaris g-tube and
spinning at 5400 rpm in an Eppendorf centrifuge. The size
range was checked on the Fragment Analyser. DNA was
treated with exonuclease V11 at 37 °C for 15 min. The
ends of the DNA were repaired as described by Pacific
Biosciences. Samples were incubated for 20 min at 37 °C
with damage repair mix supplied in the SMRTbell library
kit (Pacific Biosciences). This was followed by a 5-min
incubation at 25 °C with end-repair mix. DNA was cleaned
using 1:1 volume ratio of Ampure beads and 70% ethanol
washes. DNA was ligated to adapters overnight at 25 °C.
Ligation was terminated by incubation at 65 °C for 10 min
followed by exonuclease treatment for 1 h at 37 °C. The
SMRTbell library was purified with 1:1 volume ratio of
Ampure beads. The library was size-selected on the Blue
Pippin (Sage) in the range 7–20 kb. The DNA was recov-
ered and the quantity of library and therefore the recovery
was determined by Qubit assay and the average fragment
size determined by Fragment Analyser. SMRTbell libraries
were annealed to sequencing primers at values prede-
termined by the ‘Binding Calculator’ software (Pacific
Biosciences) and complexes made with the DNA polymerase
(P6/C4 chemistry). The complexes were bound to Magbeads
and loaded onto three SMRT cells. Sequencing was done
using 360-min movie times. Sequence data from the three
SMRT cells were assembled using the HGAP3/Quiver
assembler. This resulted in two contigs representing the
chromosome and the pSLT virulence plasmid. Terminal
repeats were manually trimmed to represent circular
molecules and the chromosome assembly was reordered
so that the sequence started at the thrL locus in accord-
ance with convention for Salmonella finished genomes.
The closed sequences for the U2 chromosome and pSLT
virulence plasmid were 4,811,399 bp and 93,862 bp,
respectively. Prokka [24] was used to annotate the two
sequences, using the –force flag to preferentially annotate
CDS from reference databases FN424405 for the chromo-
some and AE006471 for the virulence plasmid. The
finished U2 genome and annotation were submitted
to Genbank and can be accessed using the Genbank acces-
sion number LT855376 (chromosome) and LT855377
(virulence plasmid).
Genomic analysis
The multi-locus ST was determined using a modified
version of SRST [25]. For phylogenetic analysis, processed
sequence reads were mapped to the S. Typhimurium LT2
reference genome (GenBank: AE006468) using BWA mem
[26]. SNPs were called using GATK2 [27] in unified geno-
typer mode. Core genome positions that had a high-quality
SNP (>90% consensus, minimum depth 10x, MQ ≥ 30)
in at least one strain were extracted and IQ-TREE
with parameters –m TVM+ASC –bb 1000 was used to
construct a maximum likelihood phylogeny [28]. The TVM
model was chosen after using the model test functionality
built into IQ-TREE.
To examine the evolutionary history of ST313, four
timed phylogenies were constructed using BEAST v1.8.0
[29], with varying clock rate models and tree priors. The
resulting models were compared in terms of their tree
likelihood and posterior and the strict exponential and
strict constant models were found to be superior. A
comparison using AICM calculated with Tracer v1.6.0
showed that the models had very similar values, tree
topologies and branching support in terms of posterior
probability were similar between the models. The 95% HPD
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for the exponential growth rate estimate was – 0.0026 to
0.0006; the strict, constant growth model was selected as
the estimate of growth rate from the exponential model
was around 0 (i.e. constant).
Accessory genome analysis was performed using de
novo assemblies of quality processed FASTQs produced
using SPAdes v2.5.1 using default parameters except –
careful and –k 22, 33, 55, 77 [30]. Whole-genome assem-
blies were compared to the reference ST313 strain D23580
using BRIG [31].
Microbiology
Phenotypic antimicrobial susceptibility testing was carried
out for all UK-isolated ST313 strains. The antimicrobial
susceptibility testing was done using breakpoint concentra-
tions. Briefly, an agar dilution method involving Iso-sensitest
agar or Muller-Hinton agar was used to determine if isolates
were sensitive or resistant to a set concentration of indi-
vidual antimicrobials (Additional file 3: Table S3).
Swimming motility assays were performed based on
methods previously described [32]. A 3-μL aliquot of
bacteria grown overnight in LB (Lennox Broth; 10 g/L
Bacto Tryptone, 5 g/L yeast extract and 5 g/L NaCl,
pH7.0) was spotted onto LB (Lennox) plates containing
0.3% Bacto Agar (Difco). Plates were incubated at 37 °C.
After exactly 5 h, the migration diameter was measured
and plates were photographed.
Catalase activity and RDAR morphotypes were assayed
based on methods used by Singletary et al. [21]. Briefly,
for catalase activity, 20 μL of 20% aqueous H2O2 was
added to 1 mL of bacteria grown overnight in LB
(Lennox), in 1-cm diameter glass test tubes. Tubes were
photographed after 5-min incubation at room temperature
and the height of the bubble column measured. For RDAR
morphology, 2 μL of bacteria grown overnight in LB
(Lennox) were spotted onto LB plates without NaCl and
supplemented with 40 μg/mL Congo red and 20 μg/mL
Coomassie blue. Plates were incubated at 25 °C and 37 °C
for seven days without inversion. All experiments were
conducted in triplicate.
Epidemiology
Food poisoning is a notifiable disease in the UK and diagnos-
tic laboratories are obliged to report the isolation of Salmon-
ella from human clinical diagnostic samples. However, data
are frequently incomplete and detailed exposure information
for cases is not always available in retrospect. Therefore,
targeted surveillance questionnaires were attempted to
obtain enhanced information, focusing primarily on col-
lection of information on clinical severity of disease; travel
history and consumption of foods of African origin were
utilised during telephone interviews for cases reported
during 2014–2016 to collate relevant epidemiological
data. Cases for which enhanced information were avail-
able are shown in Additional file 2: Table S2.
Collection of this epidemiological data was not attempted
for the 2012 cases, but limited travel data had been
recorded on the SRS Salmonella surveillance database
for some isolates. It is important to emphasise that the
travel information for the 2012 isolates is of low quality
and the absence of reported travel does not mean that
international travel had not occurred. Odds ratios (OR)
were calculated using the medcalc.org website https://
www.medcalc.org/calc/odds_ratio.php.
Results
Epidemiology of ST313 in the UK
Between January 2014 and May 2016, 3018 S. Typhimurium
isolates from human, animal, food and environmental
sources underwent WGS by PHE, of which 79 (2.6%) were
of multi-locus ST ST313. WGS data were available for a
further 333 S. Typhimurium isolates from 2012, of which
seven (2.1%) were ST313. Of the total S. Typhimurium
isolates derived from human patients in England and Wales
in the two time periods, 2.7% (84/3147) were ST313.
The 86 UK-derived ST313 isolates (Additional file 2:
Table S2) originated from 75 individual human patients
(five patients had two isolates sequenced and one patient
had five isolates sequenced); one isolate was from a dog
and one was isolated from an unspecified raw food sam-
ple. The sample type was recorded for 72 of the 75 human
patient isolates; 13 patients had one or more isolate from
extra-intestinal sites (blood, pus or bronchial alveolar
lavage) indicating iNTS disease and 59 isolates were from
faeces alone (indicating gastrointestinal infection). Travel
information was available for 51 of the 75 human patients,
of whom eight reported travel to sSA during the estimated
disease incubation period and one adult male reported
consuming food of West African origin in London. Of the
51 patients with travel information, 48 had sample type
recorded. Of the eight patients who reported travel to
Africa, six had extra-intestinal infections. In contrast, just
two of 40 patients for whom travel information was available
and did not report travel to Africa had extra-intestinal infec-
tion, showing that travel to Africa is significantly associated
with iNTS disease in the UK (OR= 57.0 [95% confidence
interval {CI} = 6.7–484.8], p value = 0.0002) (Table 1A).
Phylogenetic analysis reveals unprecedented diversity of
ST313
All the UK-derived isolates in this study originated from
diagnostic laboratories in England and Wales. To simplify
the categorisation/differentiation of the lineages for
discussion purposes, isolates belonging to lineage 1 and
2 (including those isolated in the UK) will be referred to
as African lineages and the non-lineage 1 and 2 isolates
will be referred to as UK-ST313.
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Sequence data quality was sufficient to permit whole-
genome single nucleotide polymorphism (SNP) phylogenetic
analysis of the isolates from 76 of the 77 patient and non-
human isolates. Within the wider phylogenetic context of S.
Typhimurium, all ST313 isolates submitted to PHE formed
a monophyletic group that clustered with previously
described African ST313 isolates [7] (Fig. 1). A second
maximum likelihood ST313 phylogeny was generated with
a closely related ST19 strain also received by PHE (strain
U21) as an outlier, to study phylogenetic relationships
(Fig. 2a). Of the 76 isolates from distinct patients/sources,
12 belonged to the previously described lineage 2 and 64
did not fall within any ST313 lineage that has been re-
ported to date. No lineage 1 isolates were identified.
Where more than one isolate was derived from the same
patient, there were no core genome SNP differences be-
tween the isolates. Furthermore, the African associated
lineages 1 and 2 did not form a monophyletic group
within the novel diversity observed. Both of the African
lineages shared more recent common ancestors with
UK-associated strains than with each other. Neither the
food nor the animal isolate belonged to lineage 2.
The UK-ST313 isolates do not themselves form a coher-
ent monophyletic cluster, revealing a previously unreported
level of genetic diversity within ST313 (Fig. 1). To examine
the evolutionary history of ST313, a maximum clade
credibility tree was inferred using BEAST (Fig. 3) and the
topology was largely congruent with respect to the Max-
imum Likelihood tree (Figs. 1 and 2). The most recent
common ancestor (MRCA) of ST313 is estimated to have
been in approximately 1787 (95% highest posterior
distribution [HPD], 1735–1836). Lineage 1 diverged from
other ST313 sampled in this study in approximately 1796
(95% HPD 1744–1842), while lineage 2 diverged from
other ST313 sampled here in 1903 (95% HPD 1876–
1927). The lineage 1 MRCA dated to around 1984 (95%
HPD 1979–1987), while the lineage 2 MRCA dated to
around 1991 (95% HPD 1986–1995). These confidence
intervals overlap with the confidence intervals reported for
the emergence of the two lineages by Okoro et al., 2012 [7].
The two African lineages do not form a monophyletic group
and share an MRCA which is very close to that of ST313 as
a whole. Both lineages 1 and 2 are separated from other
sampled ST313 by long branches, indicating a distant
MRCA with other isolates and suggesting that a tight
Table 1 Summary of key epidemiological features of ST313
sampled by PHE. Full metadata for all isolates in this study is
available in Additional file 2: Table S2
A. Association between isolation source and travel to sSA. Total = 48a
Extra-intestinal
infection
Gastro-intestinal
infection
Reported travel to sSA 6 2
No reported travel to sSA 2 38
OR = 57.0 (95% CI = 6.7–484.8),
p value = 0.0002
B. Association between lineage 2 infection and travel to sSA. Total = 51b
Lineage 2 Non-lineage 2
Reported travel to sSA 7 1
No reported travel to sSA 2 41
OR = 143.5 (95% CI = 11.4–1802.9),
p value = 0.0001
C. Association between lineage 2 infection and extra-intestinal infection.
Total = 72c
Lineage 2 Non-lineage 2
Extra-intestinal infection 10 3
Gastro-intestinal infection 1 57
OR = 190.0 (95% CI = 17.9–2014.0),
p value < 0.0001
a51 individual patient isolates with travel information, but three with source unknown
b51 individual patient isolates with travel information
c75 individual human patient isolates in total, but three with source unknown.
One isolate not included in phylogeny due to poor quality sequence, so
lineage unknown
Fig. 1 UK-ST313 isolates are phylogenetically distinct from African lineages. Unrooted maximum likelihood phylogeny of ST313 in the context of
reference S. Typhimurium ST19 isolates. Isolate U21 was an ST19 isolate, closely related to ST313, that was used as an outgroup in further analyses. The
African epidemic ST313 lineages 1 and 2 are labelled
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population bottleneck has occurred relatively recently
in evolutionary history.
The association between phylogenetic context and travel
to Africa
We investigated the association between reported travel
to sSA and infection with the lineage 2 isolates. Of the
eight UK patients reporting travel to sSA during the
seven days before disease onset, seven were infected with
a lineage 2 isolate. In contrast, of the 43 patients who re-
ported no travel to sSA, two were infected with lineage 2
(Table 1B). This shows that travel to sSA was significantly
associated with infection by ST313 lineage 2 (OR = 143.5
[95% CI = 11.4–1802], p value = 0.0001).
We investigated whether the ST313 lineage 2 isolates
were more frequently associated with extra-intestinal or
gastro-intestinal infection. Of the 11 patients infected
with lineage 2 (and for which source of isolation data
was available), ten patients had isolates that originated
from extra-intestinal sites. In contrast, for the patients
infected with UK-ST313 isolates, three of 60 isolates
were from extra-intestinal sites (Table 1C). These data
show that infection with lineage 2 is significantly associ-
ated with invasive disease (OR = 190.0 [95% CI = 17.9–
2014.0], p value < 0.0001).
Salmonella isolates that are related by a common
source exposure such as a shared contaminated food
source are often within a single linkage cluster that varies
by less than five core-genome SNP differences (termed a
5-SNP cluster). The UK-derived lineage 2 isolates did not
belong to a single linkage cluster as they varied by at least
38 SNPs, with a median pairwise distance of 57 SNPs
a b
Fig. 2 UK-ST313 are associated with gastrointestinal infection and do not harbour the African lineage associated prophages, BTP1 & BTP5. a Maximum
likelihood phylogeny of 76 UK-isolated ST313 strains received by PHE in the context of 24 African ST313 sequenced by Okoro et al. [7]. Red branches
indicate ST313 lineage 1 and 2. Adjacent metadata panel showing: 1. Country isolate was associated with; Africa - orange, not Africa - blue; 2. Source;
extra-intestinal - red, faecal - brown, environmental - green, unknown - grey. b BLAST ring image showing blastn comparison of all UK-isolated ST313
genomes (red and grey rings) along with three reference ST19 strains (blue rings) against lineage 2 representative strain D23580. The position of the
prophages (coloured blocks) and Salmonella pathogenicity islands (grey blocks) in lineage 2 strain D23580 are shown around the outside of the ring
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(Additional file 3: Figure S4A). In contrast, we identified
groups of isolates that were very closely related within the
UK-ST313 (Additional file 3: Figure S4B). There were
three 5-SNP clusters which contained four, three and three
isolates in each. This level of relatedness of these UK-
ST313 is consistent with exposure to a common source.
Accessory genome signatures of ST313
MDR is a key phenotypic feature associated with both
the African ST313 lineages and is encoded by Tn21-like
integron insertions on the pSLT virulence plasmid. Analysis
of the genome sequences indicated that all 76 ST313
isolates in this study carried the pSLT plasmid. However,
the majority of the UK-ST313 isolates were antibiotic-
sensitive (59/64 were sensitive to all antimicrobials tested)
and no consistent AMR gene profile was identified. In
contrast, 10/12 UK-isolated lineage 2 isolates contained the
same pSLT-associated MDR locus as the African lineage 2
reference strain D23580 [6]. Four UK-isolated lineage 2
strains exhibited an atypical AMR gene profile; one isolate
(U45) lacked the chloramphenicol resistance catA gene
and another (U73) carried only the beta-lactamase
gene blaTEM1. A third isolate, U1, had probably acquired
resistance to fluoroquinolones via a mutation in the DNA
gyrase subunit A gene, gyrA.
The fourth atypical UK-isolated lineage 2 isolate, U60,
carried additional antibiotic resistance genes including
extended-spectrum beta-lactamases (ESBL) blaCTX-M-15
and blaOXA-1, and genes conferring resistance to amino-
glycosides, trimethoprim and tetracycline; aac(6′)-Ib-cr,
dfrA-14, tet(A)-1 (Fig. 4a). Isolate U60 also encoded the
tellurium heavy metal resistance operon (terBCDEF).
Comparison to lineage 2 reference strain D23580 identified
a 29-kb deletion in the pSLT-BT virulence plasmid [6],
which corresponded to the conjugal transfer region.
Additionally, sequence reads from strain U60 could
be mapped to 97% of the IncHI2 pKST313 plas-
mid (Additional file 3: Figure S1A), a novel plasmid which
has recently been reported in lineage 2 isolates from
Kenya and is known to encode ESBL resistance loci [33].
A more detailed analysis of the genome of isolate U60
identified that the blaCTX-M-15 gene was inserted into the
chromosome (location 1648104-1648109 on the D23580
reference genome), disrupting the ompD locus (Fig. 4b;
Additional file 3: Figure S1). ESBL resistance genes have
previously been reported in African ST313 isolates carry-
ing plasmids such as pKST313 [33, 34], but this is the first
report of a chromosomally encoded ESBL resistance gene
in S. Typhimurium ST313.
The assembled genomes of the UK-ST313 isolates were
compared to the African ST313 reference strain D23580
using BLAST (Fig. 2b). In agreement with published data
[6, 9], the majority of the core genome, including the
Salmonella Pathogenicity Island (SPI) repertoire was
conserved in the ST313 isolates in this study and in three
ST19 gastroenteritis isolates (Fig. 2b). The African ST313
Fig. 3 The timed phylogeny of all UK-isolated ST313 strains from this study and a representative sub-sample of ST313 genomes from Okoro et al. [7]. Figure
shows the maximum clade credibility tree from BEAST. Branches 95% HPD are displayed in blue for key nodes defining lineage 1 and lineage 2 (for tree
with all 95% HPD, see Additional file 3: Figure S4). Branches belonging to lineage 1 are coloured orange and branches belonging to lineage 2 are
coloured brown
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lineages carry two prophages, BTP1 and BTP5, that are
absent from ST19 strains [9, 17]. The entire BTP1 and
BTP5 prophages were found in most ST313 isolates that
belonged to African lineage 2 (12/13), but one UK-isolated
lineage 2 strain, U68, lacked both prophages. The complete
BTP1 and BTP5 prophages were not identified in any of
the UK-ST313 isolates (Fig. 2b), though some isolates con-
tained partial and fragmented identity to BTP1 and BTP5,
indicating the presence of related prophages [35, 36] which
may not occupy the same attachment site. As expected,
the st313-td gene [18, 37] was carried by all 12 lineage 2
strains isolated from the UK that contained prophage BTP1.
Only 1/51 UK-ST313 isolates contained the st313-td gene
(isolate U76), where it was located on a prophage with 90%
identity to BTP1.
To confirm the conservation of chromosomal organ-
isation in the UK-ST313 isolates, a representative isolate
U2 was re-sequenced by PacBio long-read sequencing.
The assembly produced two closed circular contigs
representing the chromosome and the pSLT virulence
plasmid (Additional file 3: Figure S2). Comparison with
the ST313 lineage 2 reference genome D23580 identified
no large chromosomal re-arrangements, deletions or du-
plications, and confirmed that the BTP1 and BTP5 attach-
ment sites were unoccupied and did not contain
additional prophages. No additional plasmids larger than
the detection limit of the PacBio sequencing (~10 kb)
were detected in isolate U2. Overall, these data show
that there is no particular prophage repertoire associ-
ated with the UK-ST313 strains.
Genome degradation and pseudogenes in UK and African
ST313
The ST313 lineages 1 and 2 responsible for iNTS disease
in Africa have undergone genome degradation [6, 9]. The
pseudogenes identified in lineage 2 representative strain
D23580 were put into the context of the high-quality
finished genome of UK-ST313 isolate U2 (Fig. 5). The
a
b
Fig. 4 Isolate U60 contains additional resistance genes including a blaCTX-M-15 locus inserted into the chromosomal ompD locus. a Antimicrobial resistance
typing data and resistance genes detected in genome sequences for isolate U60, compared to data for typical lineage 2 and UK-ST313 isolates. b Schematic
illustrating the insertion of blaCTX-M-15 element into the chromosomal ompD locus in isolate U60. Further information is given in Additional file 3: Figure S1
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majority (34/44) of pseudogene mutations were conserved
in U2. The only pseudogenes associated with characterised
genes present in lineage 2 and intact in UK-ST313 strain
U2 were macB, sseI and lpxO (Fig. 5). Of the 190 isolates
(originating from 12 patients) of lineage 2, all had dis-
ruptions to the lpxO, ratB, allP, allB, pagO and pipD
genes, showing genome degradation reported in African
lineage 2 is conserved in lineage 2 strains isolated in
the UK.
UK and African ST313 strains share key phenotypes
Several studies have associated the ability of ST313 to
cause iNTS disease with particular phenotypic characteris-
tics, such as the lack of RDAR morphotype formation, re-
duced swimming motility and the inability to produce
catalase at stationary phase [19–21, 38]. We investigated
these phenotypic characteristics in the context of the UK-
ST313 strains, using a subset of 16 UK-isolated ST313
that included 13 UK-ST313 isolates and three lineage 2
isolates. The phylogenetic context of these 16 isolates
is shown in Additional file 3: Figure S3. Lineage 2 rep-
resentative strain D23580 and ST19 representative strain
4/74 were included as positive and negative controls.
The swimming motility of UK-isolated ST313 was
highly variable between isolates (Fig. 6a). One lineage 2
strain, U1, appeared to show low levels of motility but
this strain was observed to have a growth defect (data
not shown). The ST313 lineage 2 representative strain
D23580 was less motile than ST19 strain 4/74, consistent
with previous reports [19, 20]. However, there was no
Fig. 5 The majority of pseudogenes identified in lineage 2 strain D23580 are conserved in UK-ST313 representative strain U2. Heatmap adapted from
Kingsley et al. [6] showing genome degradation in ST313 strain D23580 (first heatmap column) in the context of strain U2 (final column). Grey indicates
pseudogenes conserved in both strains, while red indicates genes which are not degraded and therefore likely to be functional, in strain U2
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apparent association between motility (as measured by
migration diameter) and phylogenetic context of the
lineage 2 strains and the UK-ST313 strains.
A non-synonymous SNP in the katE gene was reported
to be responsible for the lack of catalase activity in ST313
lineage 2 [21]. All 16 UK-isolated strains were shown to be
negative for stationary phase catalase activity, as was the
lineage 2 representative strain D23580 (Fig. 6b). In contrast,
ST19 strain 4/74 showed considerable stationary phase
catalase activity, consistent with previous findings [21].
The RDAR morphotype of S. enterica is linked to
resistance to desiccation and exogenous stresses [39].
African lineage 2 ST313 is reported to be defective
in RDAR morphotype formation due to a truncated
BcsG protein generated by a premature stop codon
[21]. All the UK-isolated strains and the African
lineage 2 reference strain D23580 did not exhibit the
RDAR morphotype. In our experiments, only the
ST19 strain 4/74 exhibited the RDAR morphotype
(Fig. 6c).
These experiments did not identify any phenotypic
differences that distinguished the UK-ST313 isolates
from ST313 lineage 2 and future work is needed to iden-
tify African ST313-specific phenotypes.
Fig. 6 In vitro phenotypes of a subset of UK-isolated ST313 strains in the context of representative ST313 lineage 2 and ST19 strains D23580 and
4/74. UK-isolated strains that belong to African lineage 2 (U1, U6 and U13) are highlighted in red throughout. a Migration diameter after 5 h (average of
three replicates is shown together with error bars representing standard deviation). A representative plate is shown, right. b Stationary phase catalase
activity represented by bubble column height after 5 min exposure to 20 μL 20% H2O2. c RDAR morphology assay. RDAR phenotype forms after prolonged
incubation at 25 °C but not at 37 °C
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Discussion
Recent reports of iNTS disease have been associated
with S. Typhimurium ST313 in sSA [6, 7, 37] and it had
been suggested that ST313 was geographically restricted
to sSA. This prompted us to investigate the presence of
ST313 among S. Typhimurium isolates from the UK.
We discovered that 2.7% of S. Typhimurium isolates
referred to PHE from human patients are of MLST ST313
and that this sequence type is heterogeneous in terms of
clinical presentation, genomic characteristics and epidemi-
ology. The UK-isolated ST313 strains are predominantly
fully antimicrobial-susceptible and cause gastroenteritis.
This was also the case with the recently described ST313
strains from Brazil [8], raising the possibility that these
isolates are more closely related to the UK-ST313 reported
here than to African lineage 2. Further work is needed to
show where Brazilian ST313 isolates fit into the popula-
tion structure of S. Typhimurium ST313.
We identified a significant association between travel to
Africa and infection with the previously described African-
associated, ST313 lineage 2. The amount of diversity
between the lineage 2 ST313 isolates from the UK
(Additional file 3: Figure S4) was not consistent with an
immediate, common source of exposure. Instead, we suggest
that these isolates were associated with travel to Africa, a
hypothesis that was supported by epidemiological data that
linked the isolates to different African countries (Table 1).
The UK-ST313 isolates, while having no large clusters
that are typical of foodborne outbreaks, did contain three
small clusters that were related at the 5-SNP level. This
pattern of relatedness is consistent with UK-ST313 isolates
being transmitted in a similar way to other gastrointestinal
Salmonella in Europe.
Our study revealed novel diversity within ST313,
which was previously restricted to two African lineages
that had exhibited recent clonal expansion [7]. Here we
place the African lineages into an evolutionary context
by showing that lineages 1 and 2 do not form a mono-
phyletic group within ST313, which is suggestive of
two separate introductions of ST313 into sSA. African
lineages 1 and 2 diverged from their inferred MRCA
with UK lineages around 1796 and 1903, respectively.
These findings reflect the limitations of classifying bac-
terial pathogens simply on the basis of sequence type
and show that in the post-genomic era, the resolution
offered by MLST may not be sufficient to describe epi-
demiologically relevant population structures.
It has been estimated that 9.2% of cases of Salmonel-
losis in the EU can be attributed to international travel
and therefore sequencing Salmonella isolated in Europe
can provide valuable information regarding the global
diversity of Salmonella associated with human disease
[40, 41]. The genome of one UK-isolated lineage 2 iso-
late associated with travel to Kenya, U60, contained
sequences with high nucleotide similarity to a recently de-
scribed IncHI2 plasmid, pKST313, that was carried by
ceftriaxone-resistant ST313 isolates from Kenya [21]. Until
now, the blaCTX-M-15 gene has only been found to be
plasmid-associated in Salmonella. We discovered that the
blaCTX-M-15 gene was chromosomally encoded in isolate
U60, causing disruption of the ompD locus which has two
implications. First, chromosomal integration ensures
stability of ESBL-resistance even in the absence of the
plasmid. Second, ompD encodes an outer membrane
porin of S. Typhimurium that is highly immunogenic
[42] and absent from S. Typhi. Accordingly, the disruption
of ompD could enhance the reported ‘stealth’ phenotype of
ST313 lineage 2 infection [19]. We note that OmpD is a
potential vaccine target for iNTS [43] and the absence of
OmpD from African ST313 populations could have impli-
cations for future iNTS vaccine development.
People infected with ST313 lineage 2 in the UK were
significantly more likely to suffer from invasive disease
than patients infected with UK-ST313 isolates. This observa-
tion provided an excellent opportunity to use comparative
genomics to relate genetic findings that have been linked to
the pathology of lineage 2 ST313 into the context of closely
related, gastrointestinal-associated strains. We found that
the only genetic characteristics common to both lineages 1
and 2 and absent from the UK-ST313 genomes were the
BTP1 and BTP5 prophages and the plasmid-associated
MDR loci. The two African lineages do not share a common
ancestor that carried either prophage, suggesting inde-
pendent acquisition of BTP1 and BTP5 by ST313
lineage 1 and 2. While the MDR loci of lineage 1 and 2
confer similar patterns of AMR, they are genetically
distinct. The maintenance of the prophage and plasmid-
encoded accessory genome in two distinct ST313 lineages
in Africa implies a strong selection pressure that caused
convergent evolution of the two African lineages. In con-
trast, we identified evidence for an assortment of distinct
prophage repertoires in the UK-ST313 isolates, indicating
an absence of selection for specific mobile elements.
Aside from the addition of mobile genetic elements
and virulence factors, genome degradation by the accu-
mulation of pseudogenes and deletion events accompan-
ies adaption to a more invasive lifestyle [13, 44]. Initial
analysis of the African ST313 representative strain
D23580 genome reported 23 pseudogenes compared to
the six present in ST19 strain SL1344 [6]. Here, we found
that the majority of genome degradation found in lineage
2 strain D23580 was conserved in UK representative strain
U2. The only pseudogenes associated with characterised
genes that were found to be specific to African lineage 2
ST313 were the SPI2-secreted effector gene sseI, lipid A
modification gene lpxO and macrolide efflux pump gene
macB, each of which could play a role in infection dynam-
ics [45–47].
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A number of the in vitro phenotypes which have been re-
ported for lineage 2 ST313, and could contribute to a host-
adapted lifestyle [19–21, 38], were examined in the UK-
ST313. Swimming motility was highly variable among the
strains tested and UK-ST313 isolates behaved identically to
African lineage 2 isolates in the catalase and RDAR mor-
photype assays. We detected no African-lineage-specific
phenotypic characteristics and speculate that reduced
motility, defective catalase activity and loss of RDAR
formation are not be directly linked to iNTS disease.
A key contributing factor to iNTS disease is host im-
munosuppression and one limitation of this retrospective
study was that the underlying health status of the patients
was unknown. This study does highlight the extraordinary
epidemiological insights that routine genomic surveillance
of pathogens by public health agencies can offer and the
ability to understand the pathogenesis of novel pathovars.
In a clinical setting, the knowledge that an immune-
compromised patient was infected with lineage 2 ST313
could impact clinical decision-making.
Conclusions
We have discovered previously unknown diversity in the
ST313 sequence type that highlights the convergent
evolution towards niche specialisation that has occurred in
the African lineages. The routine genomic surveillance of
pathogens is now being adopted internationally and will
bring an unprecedented ability to monitor emerging threats,
such as the appearance of extended-spectrum beta-
lactamase resistance. WGS of clinical isolates represents a
new window with which to view the epidemiology and
microbiology of infectious diseases.
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